Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.
Emerging infectious diseases·2026
Same author
A journey of 1000 miles begins with a single step-proteomics, hyperinflation, and chronic obstructive pulmonary disease.
Annals of the American Thoracic Society·2026
Same author
Influenza household transmission and genomic diversity in the United States: A prospective cohort study, 2022-2024.
The Journal of infection·2026
Same author
Rationale and Design of the Roflumilast or Azithromycin to Prevent COPD Exacerbations Clinical Trial.
Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author
Less Versus More Intensive Surveillance of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Beliefs About Guidelines Implemented in the Watch the Spot Trial.
Journal of the American College of Radiology : JACR·2025
Same author
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study.
Nature communications·2025
Same journal
Wearable-derived activity and physiological changes following pleural intervention in malignant pleural effusion.
Chest·2026
Same journal
The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.
Chest·2026
Same journal
A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.
Chest·2026
Same journal
Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.
Chest·2026
Same journal
Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.
Chest·2026
Same journal
Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.
Chest·2026
Related Experiment Video
Updated: Jun 14, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
COPD performance measures: missing opportunities for improving care.
John E Heffner1, Richard A Mularski, Peter M A Calverley
1Providence Portland Medical Center, 5050 NE Hoyt St, Ste 540, Portland, OR 97213, USA. John_heffner@mac.com
Chest
|March 30, 2010
Summary
Patients with Chronic Obstructive Pulmonary Disease (COPD) often miss recommended care. Developing more performance measures for COPD is crucial for improving patient outcomes and raising public awareness.
Area of Science:
- Pulmonary Medicine
- Healthcare Quality Improvement
- Health Policy
Background:
- Growing evidence indicates patients with various conditions, including COPD, frequently do not receive recommended care despite available clinical guidelines.
- COPD patients receive guideline-directed care in only 30-55% of provider encounters, posing a significant concern given its status as the fourth leading global cause of death.
Purpose of the Study:
- To highlight the critical need for developing more performance measures for COPD care.
- To emphasize the role of respiratory professional societies in addressing the deficit of COPD-specific performance measures.
Main Methods:
- Analysis of the current landscape of clinical practice guidelines and performance measures in healthcare.
- Review of quality improvement interventions and value-based reimbursement strategies.
- Assessment of the impact of performance measure availability on patient care and public awareness.
Main Results:
- A significant disparity exists in the number of performance measures for COPD compared to other conditions with less global health impact.
- The scarcity of COPD measures contributes to reduced public awareness, misallocation of quality improvement resources, and suboptimal patient care.
- Value-based reimbursement models are increasingly adopted, yet COPD lacks sufficient measures to inform these systems.
Conclusions:
- Respiratory professional societies must proactively stimulate the development of valid COPD performance measures aligned with practice guidelines.
- Coordinated development of COPD measures is essential to prevent fragmented reporting and ensure patient-centered care.
- Increased availability of COPD performance measures is vital for enhancing care quality, improving patient outcomes, and elevating public understanding of this major health condition.